Improved Drug Access in Low and Middle-Income Countries

The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(16)30068-7
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

Elsevier BV

Related search

Alcohol Burden in Low-Income and Middle-Income Countries

The Lancet
Medicine
2015English

Retinoblastoma in Low- And Middle-Income Countries

Pediatric Hematology and Oncology
Child HealthOncologyPediatricsPerinatologyHematology
2019English

Dementia in Low- And Middle-Income Countries

International Psychiatry
2006English

Rotavirus Vaccine Protection in Low-Income and Middle-Income Countries

The Lancet Infectious Diseases
Infectious Diseases
2019English

Influenza Vaccines in Low and Middle Income Countries

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2013English

Pesticide Poisonings in Low- And Middle-Income Countries

Environmental Health Insights
ManagementMonitoringMutagenesisPublic HealthEnvironmentalHealthPolicyToxicologyLawOccupational HealthPollution
2018English

The European Medicines Agency Facilitates Access to Medicines in Low- And Middle-Income Countries

Expert Review of Clinical Pharmacology
MedicineToxicologyPharmaceuticsPharmacology
2020English

Achieving Affordable Critical Care in Low-Income and Middle-Income Countries

BMJ Global Health
Health PolicyPublic HealthOccupational HealthEnvironmental
2019English

Challenges in Dementia Risk Prediction in Low-Income and Middle-Income Countries

The Lancet Global Health
Medicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy